1. Wang S ,……Wang Q*. An integrated bipolar electrode with shared cathode for dual-mode detection and imaging of CEA. Biosensors and Bioelectronics, 2024, 265:116704.
2. Wang T, ……Wang Q*. ZnS/MXene/CdS heterostructure modified electrode for ultrasensitive miRNA-21 assay with signal amplified photoelectrochemical strategy. Sensors and Actuators B: Chemical, 2024, 419.
3. Zang Y, ……Wang Q*. Improved surface-enhanced Raman scattering detection of miRNA employing polyhedral gold plasmonic nanoparticles in conjunction with DNA cascade amplification strategy. Sensors and Actuators B: Chemical, 2025, 429:137320
4. Zhong Z,……Wang Q*. Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU[J].Biomedicine & Pharmacotherapy, 2024, 170(1):1-12.
5. Wang T,……Wang Q*. Dual amplification dynamic DNA network system for CRISPR/Cas12a based p53 gene detection. Anal Chim Acta. 2024, 1321:343048.
6. Wang S, ……Wang Q*. A multichannel closed bipolar electrode-LED sensing array for simultaneous sensitive and visible detection of multiple tumor markers. Sensors and Actuators B: Chemical, 2025, 442:138071.
7. Wang T,……Wang Q*. Photocatalyst mediated FL/PEC dual-mode strategy for microRNAs logic detection based on DSN enzyme assisted amplification strategy. Biosensors and Bioelectronics.2025, 292:118062.
8. Geng C,……Wang Q*. miR-27a-3p targets CACNA2D3 to promote colorectal cancer progression via the Ca2+/ROS/mitochondrial apoptotic pathway. Biochim Biophys Acta Mol Basis Dis, 2025, 1872(3):168105.
9. Cai M,……Wang Q*. Dachsous cadherin related 1 (DCHS1) is a novel biomarker for immune infiltration and epithelial-mesenchymal transition in endometrial cancer via pan-cancer analysis. J Ovarian Res, 2024, 17(1):162.
10. Zhan F,……Wang Q*. Cucurbitacin E Alleviates Colonic Barrier Function Impairment and Inflammation Response and Improves Microbial Composition on Experimental Colitis Models. J Inflamm Res, 2024, 17:2745-2756.
11. Yang Y,……Wang Q*. Unraveling the Action Mechanism of Tubeimoside-1 against Tumor Microvessels via Network Pharmacology and Experimental Validation. J Cancer, 2024, 15(4):955-965.